NCT03498521 2025-11-19
CUPISCO
Hoffmann-La Roche
Phase 2 Completed
Clinical Trials
3 trialsNCT00360360 2013-12-04
Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00193622 2010-09-17
Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site
SCRI Development Innovations, LLC
Phase 2 Completed